Targeting transglutaminase 2 as a potential disease modifying therapeutic strategy for synucleinopathies.
作者信息
Zhang Jie, Jasutkar Hilary Grosso, Mouradian M Maral
机构信息
Robert Wood Johnson Medical School Institute for Neurological Therapeutics, and Department of Neurology, Rutgers Biomedical and Health Sciences, Piscataway, NJ, USA.
出版信息
Neural Regen Res. 2021 Aug;16(8):1560-1561. doi: 10.4103/1673-5374.303027.
Abstract
摘要
Zotero 插件